WuXi Biologics
Yongqi Wu currently serves as the Head of China Business Development at WuXi Biologics, a prominent global Contract Research, Development and Manufacturing Organization, since October 2019. Prior to this role, Yongqi Wu held multiple positions at Bristol Myers Squibb from 2014 to 2019, including Senior Director and Director, CMC Lead, as well as Scientist I/II, DS Development Lead, focusing on early-stage process development. Earlier career experience includes a Research Associate position in the Department of Chemical and Biomolecular Engineering at The Ohio State University from 2010 to 2014. Yongqi Wu holds a PhD in Chemical and Biomolecular Engineering from The Ohio State University, and two degrees from Zhejiang University: a Bachelor of Science and a Chukochen Honor Degree in Chemical and Biomolecular Engineering, along with a Chukochen Honor Degree in Entrepreneurship/Entrepreneurial Studies.
This person is not in any teams
This person is not in any offices
WuXi Biologics
16 followers
WuXi Biologics, a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing.